| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
Selective Serotonin Reuptake Inhibitors and Risk of Serotonin Syndrome as Consequence of Drug-Drug Interactions: analysis of The FDA Adverse Event Reporting System (FAERS).
Selective Serotonin Reuptake Inhibitors and Risk of Serotonin Syndrome as Consequence of Drug-Drug Interactions: analysis of The FDA Adverse Event Reporting System (FAERS).
Novella A, Elli C, Pasina L.
Med Princ Pract. 2025 Apr 25:1-12. doi: 10.1159/000546109. Epub ahead of print. PMID: 40288362.
https://karger.com/mpp/article-pdf/doi/10.1159/000546109/4368507/000546109.pdf